Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2021 年第 4 季持倉
持倉截至 2021/12/31，2022/2/11 申報。只含多頭部位，變化是跟 2021 年第 3 季比股數。
- 持股檔數
- 46
- 較 2021 年第 3 季 −20
- 總值
- $2.34 億
- 較 2021 年第 3 季 −$1,680 萬 (−6.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MORFMorphic Holding, Inc. | COM | 399,302 | $1,892 萬 | 8.1% | +128,547+47.5% | 加碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 298,545 | $1,850 萬 | 7.9% | +172,532+136.9% | 加碼 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 1,135,365 | $1,157 萬 | 4.9% | +130,365+13.0% | 加碼 | 歷史 |
| NARIInari Medical, Inc. | Stock | 125,000 | $1,141 萬 | 4.9% | −10,000−7.4% | 減碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 117,500 | $987.7 萬 | 4.2% | +40,000+51.6% | 加碼 | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 100,000 | $929.4 萬 | 4.0% | +100,000 | 新進 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 555,155 | $905.5 萬 | 3.9% | +480,814+646.8% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 241,119 | $824.6 萬 | 3.5% | +241,119 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 494,046 | $824.1 萬 | 3.5% | −160,389−24.5% | 減碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 560,000 | $784.0 萬 | 3.3% | +30,000+5.7% | 加碼 | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $773.1 萬 | 3.3% | – | – | – |
| CERECerevel Therapeutics Holdings, Inc. | COM | 225,000 | $729.5 萬 | 3.1% | −34,966−13.5% | 減碼 | 歷史 |
| ARYEARYA Sciences Acquisition Corp V | CLASS A ORD SHS | 702,500 | $680.7 萬 | 2.9% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 145,552 | $663.4 萬 | 2.8% | +20,552+16.4% | 加碼 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 400,000 | $581.6 萬 | 2.5% | +50,000+14.3% | 加碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 271,778 | $573.2 萬 | 2.4% | +271,778 | 新進 | 歷史 |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $552.9 萬 | 2.4% | – | 新進 | – |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 65,000 | $550.8 萬 | 2.3% | +65,000 | 新進 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 1,049,721 | $543.8 萬 | 2.3% | +74,721+7.7% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 77,500 | $523.8 萬 | 2.2% | +17,500+29.2% | 加碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 419,144 | $472.0 萬 | 2.0% | +215,961+106.3% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 150,500 | $470.2 萬 | 2.0% | +100,500+201.0% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 500,000 | $402.5 萬 | 1.7% | −32,030−6.0% | 減碼 | – |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 400,000 | $397.2 萬 | 1.7% | −200,000−33.3% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 100,000 | $386.4 萬 | 1.6% | +59,846+149.0% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 175,000 | $383.1 萬 | 1.6% | +175,000 | 新進 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,122,244 | $379.3 萬 | 1.6% | +1,122,244 | 新進 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 165,000 | $360.2 萬 | 1.5% | +84,772+105.7% | 加碼 | 歷史 |
| CRISCuris Inc | COM NEW | 650,000 | $309.4 萬 | 1.3% | +75,000+13.0% | 加碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 300,000 | $300.0 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| Environmental Impact Acqu Co29408N106 | COM CL A | 300,000 | $297.6 萬 | 1.3% | 00.0% | 不變 | – |
| MRTXMirati Therapeutics, Inc. | COM | 20,000 | $293.4 萬 | 1.3% | −7,500−27.3% | 減碼 | 歷史 |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 300,000 | $291.6 萬 | 1.2% | 00.0% | 不變 | – |
| PRCTPROCEPT BioRobotics Corp | COM | 100,000 | $250.1 萬 | 1.1% | +21,466+27.3% | 加碼 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 150,000 | $187.1 萬 | 0.8% | +150,000 | 新進 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 50,000 | $155.2 萬 | 0.7% | −150,000−75.0% | 減碼 | 歷史 |
| Bio Green Med Solution, Inc.23254L603 | COM | 400,000 | $154.8 萬 | 0.7% | 00.0% | 不變 | – |
| NTLAIntellia Therapeutics, Inc. | COM | 10,000 | $118.2 萬 | 0.5% | −5,000−33.3% | 減碼 | 歷史 |
| RCORRenovacor, Inc. | COM | 125,000 | $96.3 萬 | 0.4% | +10,000+8.7% | 加碼 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 190,000 | $83.4 萬 | 0.4% | 00.0% | 不變 | – |
| HYPRHyperfine, Inc. | COM CL A | 76,162 | $55.2 萬 | 0.2% | +76,162 | 新進 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 72,406 | $44.6 萬 | 0.2% | +72,406 | 新進 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 100,759 | $40.3 萬 | 0.2% | −97,000−49.0% | 減碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 20,000 | $38.2 萬 | 0.2% | −130,000−86.7% | 減碼 | 歷史 |
| Renovacor, Inc.75989E114 | *W EXP 99/99/999 | 75,000 | $4.30 萬 | <0.1% | 00.0% | 不變 | – |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 33,333 | $2.40 萬 | <0.1% | 00.0% | 不變 | – |
選擇權（9 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| FLNAFilana Therapeutics, Inc. | COM | $1,530 萬 | – |
| MRNAModerna, Inc. | Stock | $761.9 萬 | – |
| NVAXNovavax Inc | COM NEW | $715.4 萬 | – |
| CRISCuris Inc | COM NEW | – | $499.8 萬 |
| Curevac N VN2451R105 | COM | – | $171.6 萬 |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | – | $153.1 萬 |
| SEERSeer, Inc. | COM CL A | – | $114.1 萬 |
| INOInovio Pharmaceuticals, Inc. | COM NEW | – | $99.8 萬 |
| RFLRafael Holdings, Inc. | COM CL B | $51.6 萬 | – |
2021 年第 3 季之後清倉（30 檔）
2021 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 3 季股數 | 2021 年第 3 季市值 | 2021 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| OCULOcular Therapeutix, Inc | COM | 750,000 | $750.0 萬 | 3.0% | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 35,350 | $608.4 萬 | 2.4% | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 35,910 | $572.4 萬 | 2.3% | 歷史 |
| NSTGNS Wind Down Co., Inc. | COM | 75,000 | $360.1 萬 | 1.4% | 歷史 |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 200,000 | $351.2 萬 | 1.4% | – |
| Gossamer Bio, Inc.38341PAA0 | NOTE 5.000% 6/0 | – | $208.7 萬 | 0.8% | – |
| HARPHarpoon Therapeutics, Inc. | COM | 250,000 | $197.5 萬 | 0.8% | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 75,000 | $191.1 萬 | 0.8% | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 10,000 | $184.6 萬 | 0.7% | 歷史 |
| AFIBAcutus Medical, Inc. | COM | 200,000 | $176.8 萬 | 0.7% | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 15,000 | $164.3 萬 | 0.7% | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 650,000 | $157.3 萬 | 0.6% | 歷史 |
| BFLYButterfly Network, Inc. | COM CL A | 150,000 | $156.6 萬 | 0.6% | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 150,000 | $147.0 萬 | 0.6% | 歷史 |
| SDGRSchrodinger, Inc. | COM | 25,000 | $136.7 萬 | 0.5% | 歷史 |
| PCVXVaxcyte, Inc. | COM | 50,000 | $126.9 萬 | 0.5% | 歷史 |
| ZYMEZymeworks Inc. | COM | 38,814 | $112.7 萬 | 0.4% | 歷史 |
| CELLBruker Cellular Analysis, Inc. | COM | 55,000 | $107.6 萬 | 0.4% | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 111,400 | $106.4 萬 | 0.4% | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 20,000 | $105.2 萬 | 0.4% | 歷史 |
| BHVNBiohaven Ltd. | COM | 7,500 | $104.2 萬 | 0.4% | 歷史 |
| LUNGPulmonx Corp | COM | 25,000 | $90.0 萬 | 0.4% | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 100,000 | $77.9 萬 | 0.3% | – |
| IPHAInnate Pharma SA | SPONSORED ADS | 125,000 | $77.1 萬 | 0.3% | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 50,000 | $64.7 萬 | 0.3% | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 125,000 | $63.6 萬 | 0.3% | 歷史 |
| Beauty Health Co88331L116 | EQUITY WRT | 34,400 | $49.8 萬 | 0.2% | – |
| KROSKeros Therapeutics, Inc. | COM | 12,500 | $49.5 萬 | 0.2% | 歷史 |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 250,000 | $44.5 萬 | 0.2% | – |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 50,000 | $24.2 萬 | 0.1% | 歷史 |